PDGFRB and myeloproliferative neoplasm: This case report has certain limitations, particularly in terms of generalizability—for example, the possibility of a pre-existing myeloproliferative neoplasm (MPN) with adverse mutations preceding the acquisition of the PDGFRB rearrangement cannot be excluded.